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Abstract
Objective: Cytokine imbalance might have a pivotal role
in hypercoagulability seen in preeclampsia. Our objective
was to determine the relationship of blood coagulation
related factors in placental tissue and peripheral blood in
preeclamptic and normal pregnancies.
Methods: We compared mRNA and protein levels of tis-
sue-type plasminogen activator (t-PA), plasminogen acti-
vator inhibitor-1 (PAI-1), and tissue factor (TF) in the
placenta of normal and preeclamptic pregnancies. Pla-
cental and peripheral blood t-PA and PAI-1 levels were
examined. Trophoblasts were used to study the effects
of hypoxia, hypoxia-reperfusion, and inflammatory cyto-
kines on t-PA, PAI-1, tissue factor pathway inhibitor
(TFPI), and TF.
Results: PAI-1 and TF mRNA and protein levels were
higher in placental tissue of preeclamptic pregnancies
and in the peripheral blood of patients with preeclampsia.
mRNA and protein secretion of TF, TFPI, PAI-1, but not
t-PA, was increased in trophoblast cell culture under
hypoxia and hypoxia-reoxygenation. Cell cultures with
high levels of tumor necrosis factor-alpha (TNF-a) exhib-
ited increased expression and secretion of TF and PAI-
1, decreased TFPI, and no significant change of t-PA.
Conclusions: Imbalanced synthesis of t-PA, PAI-1, TFPI,
and TF in trophoblasts may contribute to hypercoagula-
bility in patients with preeclampsia.
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Introduction
Individuals with preeclampsia and eclampsia frequently
exhibit a hypercoagulability state that includes intravas-
cular coagulation, microthrombosis, and impaired utero-
placental circulation w16x. This hypercoagulable state
significantly increases the incidence of complications
and worsens the prognosis for mother and baby w16x.
Thus far, the mechanism of hypercoagulability is not
clear. Recent studies indicate that during normal preg-
nancy trophoblasts synthesize and secrete large
amounts of cytokines, some of which have important
regulatory roles in the placental and systemic coagulation
and fibrinolytic systems. These cytokines often exist as
pairs, i.e., as activators and inhibitors, and the delicate
balance between them is important for the maintenance
of normal placental blood flow and peripheral blood clot-
ting w18x. For example, trophoblasts secret tissue-type
plasminogen activator (t-PA) and urokinase-type plas-
minogen activator (u-PA). t-PA and u-PA modify inactive
plasminogen and change it to active plasmin with exten-
sive proteinase potential w3x. In order to maintain coag-
ulation and balance of the fibrinolytic system,
trophoblasts also secrete plasminogen activator inhibi-
tors (PAIs) of the serine protease inhibitor family that
inhibit the activities of t-PA and u-PA. Over-expression of
PAI-1 can inhibit fibrin degradation, thus leading to fibrin
deposition around villi and impairment of nutrient
exchange in the placenta w9x. Additionally, trophoblasts
can express tissue factors (TFs). The interaction between
TFs and factor VIIa can initialize the external coagulation
pathway. Trophoblasts also express tissue factor path-
way inhibitor (TFPI), which inhibits the activity of TFs.
It has been shown that placental spiral arteries have
incomplete recasting in patients with preeclampsia, and
the blood flow in the intervillus space fluctuates. Doppler
ultrasound studies have shown that the fluctuations of
blood flow in the uterine arteries of patients with pre-
eclampsia were significantly higher than in normal preg-
nancies w16x. Based on this, Burton et al. claimed that
placental ischemia and hypoxia were not sustained and
that hypoxia-reperfusion injury instead of stable chronic
hypoxia might be the primary cause of tissue damage
w6x. Under hypoxia and hypoxia-reperfusion conditions,
the synthesis and release of tissue necrosis factor (TNF)-a
in placental tissue by villi mesenchymal cells and mac-
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rophages increased significantly w25x. Clinical studies
have confirmed that TNF-a levels are 2–3 times higher
in patients with preeclampsia than in normal pregnancy
w4, 18x.
In this study, we compared mRNA and protein levels
of t-PA, PAI, and TF in the placental tissue of normal and
preeclamptic pregnancies. The relationship between pla-
cental and peripheral blood t-PA and PAI levels was also
studied as well as the effects of hypoxia, hypoxia-reper-
fusion, and inflammatory cytokines on t-PA, PAI, TPPI,
and TF expression.
Materials and methods
Subjects and cell sources
Forty women who delivered at the obstetric department of Renji
hospital from March 2004 to December 2006 were studied; 20
had severe preeclampsia and 20 had normal pregnancies. Pre-
eclampsia was diagnosed according to the criteria of the Inter-
national Society for the Study of Hypertension w1x. Severe
preeclampsia was defined as a sustained blood pressureG160/
110 mm Hg, proteinuria G5 g/24 h, and multi-organ involve-
ment, i.e., renal, liver, cardiac, and/or brain damage w1x.
Hypercoagulability was confirmed by a prothrombin time (PT)
shortened )3 s compared to control, serum d-dimer )0.5
mg/L, and positive serum fibrin degradation products (FDPs).
Patients had no history of primary hypertension, diabetes,
chronic nephritis or other renal disease, blood dyscrasias, clot-
ting disorders, or previous eclampsia or preeclampsia.
Trophoblast cells were acquired from the family planning clinic
at our hospital from May 2005 to December 2005 from 10
women at 7- to 9-weeks’ gestation who underwent elective ter-
mination of pregnancy. Patients were 22–33 years old, without
high blood pressure, heart disease, chronic glomerulonephritis,
other medical conditions, or history of eclampsia or preeclamp-
sia. Ultrasound was used to confirm gestational age before ter-
mination. Specimens were pooled prior to use in subsequent
studies.
Specimen collection and preservation
Before cesarean or vaginal delivery, 4.5 mL maternal venous
blood was collected into tubes containing 0.5 mL EDTA. Sam-
ples were centrifuged at 2000 rpm for 10 min, and then 1 mL
plasma was extracted and stored at –308C. After delivery of the
placenta, blood and tissue samples were immediately collected
under aseptic conditions from the center of the maternal side of
the placenta, opposite to the site of umbilical cord attachment.
The depth of sampling was the outer 1/3 of the placenta thick-
ness. All samples were collected from this area to achieve con-
sistent sampling. The collection procedure did not exclude
deciduas; thus, some decidual tissue may have been mixed in
the samples. Tissue blocks sized 0.5=0.5=0.5 cm3 were
washed with phosphate buffered saline (PBS) and then placed
in liquid nitrogen for RNA and protein extraction.
Isolation and culture of trophoblasts
The methods of isolation and culture of trophoblasts were
described by Aharon w2x. In short, villi were rinsed with PBS and
cut into 1–2 mm3 pieces, digested by 0.125% trypsin for 30 min,
and then by 25 U/mL clarity II collagenase for 15 min. Samples
were then filtered with a 100 mm double-layered nylon net, and
centrifuged at 2000 rpm for 20 min. The supernatant was dis-
carded and the cells were suspended and allowed to settle in a
1.25–2.5% bovine serum albumin (BSA) density gradient for 1 h.
The trophoblasts were then collected and suspended in Dulbec-
co’s modified Eagle media (DMEM)qF12 culture medium and
cell supernatant liquid was prepared to make the concentration
of trophoblasts 2=106/mL. Cells were cultured on pre-treated
plates (24 h prior to culture, plates were covered with matrix gel)
at 378C in a 5% CO2 incubator overnight. After 24 h the cultures
were examined using an inverted microscope and the adhesions
between the cells and the wall were noted to be good. The
medium was changed and the culture continued to 72 h at which
point cell growth, division, and syncytium phenomenon in
merged cells were seen. Cells were then divided into groups for
study.
Experimental grouping of the primary trophoblasts
Placental trophoblasts were inoculated onto 24-well plates, each
well containing 1=106 cells. Three wells were used for each
group. The groups were: 1) control, cultured in a 5% CO2 incu-
bator at 378C for 24 h; 2) IL-10 group, 10 ng/mL IL-10 added,
cultured in a 5% CO2 incubator at 378C for 24 h; 3) IL-12 group,
20 ng/mL IL-12 added, cultured in a 5% CO2 incubator at 378C
for 24 h; 4) TNF-a group, 20 ng/mL TNF-a added, cultured in
5% CO2 incubator at 378C for 24 h; 5) hypoxia group, cultured
in a 2% oxygen, 5% CO2, 93% N2 gas incubator at 378C, for
24 h; 6) hypoxia-reoxygenation group, cultured in a 2% oxygen,
5% CO2, 93% N2 gas incubator at 37, for 24 h, then after medi-
um change, cultured in a 5% CO2 incubator at 378C for 24 h.
The supernatant was collected from the culture, and after cen-
trifugation, 0.5 mL was stored –808C for later testing. The cul-
tured medium in the culture wells was emptied and 0.5 mL
TRIzol reagent was added into the wells to destroy the cells. The
cell lysate in the wells was collected and preserved in liquid
nitrogen.
ELISA measurement of TF, TFPI-1, TFPI-2, t-PA,
and PAI-1 in serum and cell culture supernatant
TF, TFPI-1, and TFPI–2 quantification was performed with ELISA
kits manufactured by ASSAYPRO LLC (St. Charles, MO, USA).
t-PA and PAI-1 quantification was performed with ELISA kits
manufactured by Sun Biotechnology Ltd. (Shanghai). Methods
and steps described in the package insert of the respective kits
were strictly followed.
Quantitative RT-PCR assay of TF, TFPI-1, TFPI-2,
t-PA, PAI-1, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA expression in
placental tissue
Total RNA was extracted according to the TRIzol Reagent Kit
manual (Invitrogen, Carlsbad, USA). The expression level of the
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Table 2 Comparison of t-PA, PAI, and TF protein levels in
placental tissue from normal and preeclamptic pregnancies.
Normal pregnancy Preeclampsia
(ns20) (ns20)
t-PA 0.13"0.06 0.11"0.06
PAI-1 0.17"0.05 0.22"0.06a
TF 0.44"0.13 0.66"0.13a
Results are shown as mean"SD of relative unit.
aP-0.05.
Table 1 Comparison of t-PA, PAI-1, and TF mRNA levels in
placental tissue from normal and preeclamptic pregnancies.
Normal pregnancy Preeclampsia
(ns20) (ns20)
t-PA 2.16"1.22 1.70"0.88
PAI-1 59.52"47.29 66.15"27.70a
TF 10.32"3.86 16.64"6.49a
Results are shown as mean"SD of –DDCT value.
aP-0.05.
GAPDH gene was used for normalization. The sequences of the
primers for the genes were as follows:
PAI-1: PAI-forward, CAGACCAAGAGCCTCTCCAC; PAI-reverse,
ATCACTTGGCCCATGAAAAG.
t-PA: t-PA-forward, CCATGCCCGATTCAGAAGAG; t-PA-reverse,
GGCCCTGGTATCTATTTCA.
TF: TF-forward, CCGAACAGTTAACCGGAAGA; TF-reverse,
TCAGTGGGGAGTTCTCCTTC.
TFPI-2: TFPI-2-forward, GGAGCCAACAGGAAATAACG;
TFPI-2-reverse, CCGGCAAACTTTGGGAACTT.
TFPI-1: TFPI-1-forward, GCCACCACTGAAACTTATGC;
TFPI-1-reverse, TCTCAAATTGTTCATATTGCCCA.
GAPDH: GAPDH-forward,
GAAGGTGAAGGTCGGAGTC; GAPDH-reverse, GAAGATGGT-
GATGGGATTTC.
Quantitative RT-PCR was conducted according to the meth-
ods recommended by Takara (Japan) and UVItec (Cambridge,
UK) with GAPDH included for normalization. In short, Takara pre-
mix Ex Tag Real-time PCR system was used. A 5 mL sample of
PCR products was mixed with 1 mL loading buffer containing
0.5 mg/mL ethidium bromide (EB) (also provided by the kit) then
loaded on 1.5% agarose gel for electrophoresis. The UVIpro gel
image analysis system (UVItec) was used to observe the sample
and take pictures. UVI Band and SDS2.1 software (supplied with
the UVIpro system) was used to analyze the CT value of each
sample. (When templates were amplified to a certain copy num-
ber, the exponential amplification of PCR reaction became
observable. CT value is the reaction circle numbers required to
observe the exponential phase of the PCR reaction.) A stan-
dardized –DDCT value was calculated (a larger value indicates
a greater number of initial copies). yDDCT values2 minus (CT
value of the target gene minus the CT value of GAPDH gene
from the same sample).
Western blot analysis of t-PA and PAI-1 protein
levels in placental tissue
Protein samples were extracted and concentrated following the
directions in the TRIzol manual. Protein quantification was done
using a Biophotometer UV spectrophotometer (Eppendorf,
Germany). The protein samples were electrophoresed at 100mg
total protein per lane for each sample, and then transferred onto
nitrocellulose membrane. 10% skim milk (diluted by Tris-buf-
fered saline containing Tween-20 wTBSTx) was used for blocking
the membrane at room temperature for 1 h. After overnight incu-
bation at 48C with rat anti-human-t-PA antibodies, or rat anti-
human-PAI-1 antibody (American Diagnostic Inc., Santa Cruz,
CA, USA), the membrane was rinsed twice with PBS then incu-
bated with rabbit anti-rat antibody (Amersham, Piscataway, NJ,
USA) at a dilution of 1:100 at 378C for 1 h. Bands on the
membrane were visualized on X-ray films by the Enhanced
Chemical Fluorescence assay (ECF) (Amersham) following the
manufacturer’s directions. X-ray film scanning and analysis was
performed with Gel-Pro Analyzer software (Amersham). The rel-
ative content of the target protein was the ratio of the intensity
of the target protein bands to that of the GAPDH bands.
Statistical analysis
The SAS statistical package (SAS Institute Inc., Cary, NC, USA)
was used for statistical analysis. Measurements were shown as
arithmetic mean"standard deviation (mean"SD); a group
t-test was performed. P-0.05 indicated significance. Linear
regression was conducted to test the association; P-0.05 indi-
cates significant association.
Results
The mRNA level of TF and PAI-1 genes in placental tissue
in preeclampsia was higher than in a normal pregnancy
without significant difference between the levels of t-PA
mRNA (Table 1). PAI-1 protein level was higher in pla-
cental tissue in preeclampsia than in normal pregnancy
without significant difference in the protein level of t-PA
(Table 2).
Peripheral blood levels of t-PA in patients with pre-
eclampsia were significantly lower compared to those in
women with a normal pregnancy. Conversely, peripheral
blood levels of PAI-1 in patients with preeclampsia were
significantly increased compared to those in women with
a normal pregnancy (Table 3). No significant correlation
between peripheral PAI-1 levels and placental PAI-1 in
either normal or preeclamptic patients was found. In pre-
eclamptic patients, however, peripheral blood t-PA levels
were positively correlated with placental t-PA protein lev-
els (P-0.05, Table 4).
TF, TFPI-1, TFPI-2, and PAI-1 gene expression in the
hypoxia and hypoxia-reoxygenation groups were signifi-
cantly higher than in controls. Additionally, TFPI-1 gene
expression in the hypoxia-reoxygenation group was sig-
nificantly higher than in the hypoxia group (P-0.01). With
TNF-a stimulation, TF, TFPI-2, and PAI-1 gene expres-
sion in trophoblasts increased greatly and were signifi-
cantly different from that of the control group, whereas
TFPI-1 gene expression decreased and was significantly
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Table 3 Comparison of t-PA, PAI, and TF blood levels in normal
and preeclamptic pregnancies.
Normal pregnancy Preeclampsia
(ns20) (ns20)
t-PA (ng/mL) 67.12"18.91 42.03"16.08a
PAI-1 (ng/mL) 63.15"8.88 81.37"4.87a
TF (pg/mL) 30.84"9.04 53.02"8.64a
Results are shown as mean"SD.
aP-0.01.
Table 4 Correlation between t-PA, PAI-1, and TF protein levels
in peripheral blood and placental tissue in normal and pree-
clamptic pregnancies.
Correlation P-value
coefficient (r)
t-PA Normal pregnancy –0.1176 )0.05
Preeclampsia 0.4833 -0.05
PAI-1 Normal pregnancy –0.0419 )0.05
Preeclampsia 0.1962 )0.05
TF Normal pregnancy 0.2794 )0.05
Preeclampsia 0.9471 -0.01
Table 6 Effects of hypoxia and cytokines on the secretion of the blood coagulation related factors in the trophoblasts.
Groups TF (pg/mL) TFPI (ng/mL) t-PA (ng/mL) PAI-1 (ng/mL)
Mean"SD Mean"SD Mean"SD Mean"SD
Control 126.72"5.60 3.74"0.32 4.32"1.01 40.31"7.18
Hypoxia 138.71"4.79a 4.80"0.49a 3.91"0.78 87.62"9.97a
Hypoxia-reoxygenation 148.22"6.74a,b 5.30"0.56a 2.34"1.68a 100.70"7.17a,b
IL-10 130.79"4.34 3.98"0.82 4.34"1.26 33.89"7.58
IL-12 128.83"7.09 4.12"0.76 4.00"2.06 35.75"6.13
TNF-a 142.29"5.58a 3.19"0.44a 3.52"0.79 63.68"7.24a
Results are shown as mean"SD.
aStatistically significant compared with the control group (P-0.01).
bStatistically significant between the hypoxia and hypoxia-reoxygenation group (P-0.01).
Table 5 Effects of hypoxia and cytokines on the gene expression of the blood coagulation related factors in the trophoblasts.
Group TF TFPI-1 TFPI-2 t-PA PAI-1
Control 0.31"0.06 91.68"11.48 8.24"0.81 0.29"0.03 11.26"0.58
Hypoxia 0.60"0.02a 138.39"39.08a,b 15.60"3.64c 0.31"0.06 14.65"1.89b,c
Hypoxia-reoxygenation 0.69"0.29c 142.54"26.21c,d 12.50"1.69c 0.24"0.07 16.49"2.55c
IL-10 0.29"0.07 98.13"12.95 7.86"1.31 0.27"0.07 10.99"2.42
IL-12 0.33"0.03 106.17"36.18a 8.36"0.92 0.29"0.07 9.26"2.37
TNF-a 0.72"0.12c 62.89"31.29c 13.21"1.30c 0.25"0.08 43.73"3.22c
Results are shown as mean"SD of –DDCT value.
aStatistically significant compared with the control group (P-0.05).
bStatistically significant between hypoxia and TNF-a groups (P-0.01).
cP-0.01.
dStatistically significant between hypoxia and hypoxia-reoxygenation groups (P-0.01).
lower than in the control group. The gene expression of
PAI-1 was significantly higher than in the control group
and the hypoxia group. IL-10 at 20 ng/mL did not sig-
nificantly affect gene expression but IL-12 at 20 ng/mL
significantly increased the mRNA expression of TFPI-1
compared to the control group. No significant effects on
other cytokines examined were noted. Finally, the
expression of t-PA mRNA in trophoblasts was very low,
and was not affected by hypoxia or inflammatory factors
(Table 5).
Testing the supernatant of cell culture showed that in
hypoxia and hypoxia-reoxygenation culture conditions,
the concentrations of TF, TFPI, and PAI-1 increased sig-
nificantly compared to the control group (P-0.01). t-PA
level was not significantly different from that of the con-
trol group under the hypoxia condition, but it was signif-
icantly lower under the hypoxia-reoxygenation condition.
TNF-a at 20 ng/mL significantly increased the secretion
of TF and PAI-1 and decreased the secretion of TFPI
compared to the control group (P-0.01), but had no sig-
nificant effect on the secretion of t-PA. IL-10 and IL-12
at 20 ng/mL did not have any significant effect on the
secretion of coagulation related factors (Table 6).
Discussion
Results of this study show that TF and PAI-1 gene
expression and protein levels in the placental tissue of
preeclamptic pregnancies are higher than those in normal
pregnancy. Likewise, TF and PAI-1 concentrations in the
peripheral blood of patients with preeclampsia are sig-
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nificantly increased compared to those in a normal preg-
nancy. These results suggest that high expression of
PAI-1 and TF in the placenta and the secretion of these
cytokines into the blood by placental tissue might be
associated with the hypercoagulable state seen in pre-
eclampsia. Correlation analysis showed that PAI-1 levels
in peripheral blood in both normal and preeclamptic
pregnancies were not significantly correlated with local
placental PAI-1 levels. This suggests that the cause of
increased peripheral PAI-1 in preeclampsia is multifac-
torial. Additionally, vascular endothelial cells, neutrophils,
and macrophage activation may also play a role in
increasing PIA-1 levels w17x.
The results of this study also showed that patients with
preeclampsia had significantly decreased t-PA concen-
trations as compared with normal pregnancy. The phys-
iological effects of t-PA are to decrease the activity of the
fibrinolytic system, thus causing a relative increase of
coagulation activity. The data indicate that t-PA gene
expression and protein levels in the placentas of patients
with preeclampsia are not significantly different from
those in normal pregnancy. A previous study showed that
placental area and total number of trophoblast cells in
preeclampsia was less than in normal pregnancy w14x.
Therefore, it was speculated that the overall t-PA secre-
tion from the placenta in preeclamptic patients must be
less than in normal pregnancy, potentially contributing to
the lower peripheral t-PA level in preeclamptic patients.
Gao et al. w10x found that patients with preeclampsia had
increased plasma PAI-1 levels, and there existed an
imbalance between the plasminogen activators (t-PA,
u-PA) and inhibitor (PAI-1). They concluded that this
imbalance might be one of the reasons for the onset of
preeclampsia. Our results support this theory, and also
suggest that the imbalance of expression levels of the
plasminogen activators and inhibitors in placental tissue
may be a contributing factor to their imbalance in
patients with preeclampsia.
Studies have demonstrated that t-PA levels vary with
gestational age, but the increase of t-PA in late pregnan-
cy is insignificant w5, 22x. It has also been demonstrated
that the t-PA production of trophoblast is unaffected by
estrogen (E2) and progestogens (P) w24x. These obser-
vations are consistent with the findings in the present
study, which suggest the t-PA expression in trophoblasts
is relatively consistent and independent of the other fac-
tors studied.
Solovey et al. w23x reported that the hypoxia-reperfu-
sion injury could cause significantly increased expression
of TF in vascular endothelial cells, but no reports are
available on the effects of hypoxia-reperfusion injury on
the expressions of blood coagulation related cytokines in
trophoblasts. This study found that under hypoxic con-
ditions, trophoblast cell TF, TFPI, TFPI-2, and PAI-1 gene
expression and protein secretion were significantly
increased, whereas t-PA caused no significant changes.
After 24 h hypoxia followed by 24 h reoxygenation, the
gene expression of TF, TFPI, and PAI-1 was not signifi-
cantly different than that of the hypoxia group; however,
the secretion of TF and PAI-1 was further increased.
Additionally, t-PA gene expression and associated pro-
tein level significantly decreased. TFPI-2 mRNA
expression declined slightly in hypoxia-reoxygenation
conditions. Increased PAI-1 expression can inhibit t-PA
activation of plasminogen to plasmin leading to inhibition
of fibrin degradation and deposition of fibrin deposits in
placental tissue.
Elevated levels of TNF-a in the peripheral blood of
patients with preeclampsia can activate vascular endo-
thelial cells and monocytes, enabling their synthesis and
release of tissue factors, including PAI-1 w13, 19, 20x.
This study found that trophoblasts might also participate
in the process. TF and PAI-1 gene expression was sig-
nificantly increased in trophoblasts by TNF-a at 20
ng/mL, and the degree of their increase was higher than
under hypoxic conditions. Kwaan et al. w15x found that
stimulated by TNF-a, TF gene expression and protein
synthesis in cultured trophoblasts of patients with pre-
eclampsia were significantly higher than in a normal
pregnancy. They believe this phenomenon cannot be
explained by TNF-a induced cell apoptosis, and specu-
late that TF gene expression in trophoblasts of patients
with preeclampsia has a unique genetic sensitivity to
TNF-a stimulation.
The tissue factor pathway (extrinsic pathway) is the pri-
mary process responsible for intravascular blood coag-
ulation in pregnancy. TF is the primary trigger whereas
TFPI is the major inhibitor. TFPI-1 binds with TF and fac-
tor VIIa to form a triplex and in turn inhibits the activation
of factor X to block the formation of thrombin. TFPI-1 can
be produced by placenta syncytiotrophoblasts, Lang-
hans cells, and endothelial cells w8x. Knock-out of TFPI
causes abnormal embryonic development, which sug-
gested that TFPI is equally important as TF in mainte-
nance of a balanced coagulation state at the maternal-
fetal interface w11x. TFPI-2, first identified in placenta,
inhibits amino acid degradation caused by multiple
enzymes, including the TF-VIIa complex. However, TFPI-
2 does not affect the activation of t-PA, u-PA, APC, and
factor Xa w21x. TFPI-2 is produced by trophocytes and
endothelial, epithelial, and smooth muscle cells. Because
60–90% of TFPI-2 is deposited in the extracellular
matrix, TFPI-2 level in circulation is normally low w12x.
However, in the late stage of pregnancy, a large amount
TFPI-2 is synthesized by the placenta and its level in cir-
culation increases significantly w7x.
The contribution of other tissue/cell types to pre-
eclampsia cannot be excluded by the data presented,
which is a limitation of the study. However, studies have
suggested that trophoblasts play an active role in t-PA
and TF secretion in normal pregnancy, whereas endothe-
lial cell function is not significantly altered w3, 20x. This
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was the rationale leading us to focus on the trophoblast
in the present study. Indeed, experimental data are need-
ed to clarify the role of endothelial cells in preeclampsia,
and this is a topic of future studies.
In summary, this study showed that the imbalanced
synthesis and secretion of the blood coagulation and
fibrinolysis related cytokines, including t-PA, PAI-1, TFPI,
and TF in trophoblasts may promote hypercoagulability
in patients with preeclampsia. The hypoxia-reperfusion
injury, and subsequent high TNF-a in placental tissue
might lead to imbalanced cytokine gene expression in
trophoblasts. The present data suggest the role of tro-
phoblasts in cytokine imbalance seen in peripheral blood.
The significance and importance of their participation are
to be further determined.
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